An Alzheimer’s drug, verubecestat, has been shown to effectively “switched off” the production of toxic amyloid proteins that lead to the sticky plaques seen in the brains of Alzheimer’s patients by halting the steady production of amyloid-beta proteins through blocking a brain enzyme called BACE1.

See the source article by following the link below:
An Alzheimer’s drug, verubecestat, has been shown to effectively “switched off” the production of toxic amyloid proteins that lead to the sticky plaques seen in the brains of Alzheimer’s patients by halting the steady production of amyloid-beta proteins through blocking a brain enzyme called BACE1.